China Manufacturer Supply Vildagliptin Powder Type 2 Diabetes Treatment Drug Medical Grade
What is Vildagliptin?
Vildagliptin (previously LAF237, trade names Galvus, Zomelis,) is an oral anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas. Vildagliptin has been shown to reduce hyperglycemia in type 2 diabetes mellitus.
Vildagliptin Certificate of Analysis
Product name
Vildagliptin
CAS No.
274901-16-5
Outer Packing
1kg/bag
Production date
2018/2/26
Shelf life
2020/2/25
Standard adopted
Enterprise Standard
Items of analysis
Specification
Results
Appearance
White or almost white powder
white powder
Solubility
Sparingly soluble in methanol;slightly soluble in ethanol
Complies
Identification
Identical to the HPLC retention of standard
Complies
.
Identical to the IR specyrum of standard
Complies
Loss on drying
≤1.0%
0.18%
Melting point
145.0℃-155.0℃
149.4℃-152.2℃
Residue on ignition
≤0.20%
0.05%
R-isomer
≤0.5%
0.05%
Impurity A
≤0.15%
ND
Impurity B
≤0.15%
0.02%
Heavy metals
≤20ppm
<20ppm
DMF
≤880ppm
ND
chloroform
≤60ppm
ND
Conclusion
Qualified
Enquiry Form ( we will get back you as soon as possible )
